Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection — EDT BioFilm  

Wound Heal Clinical Trial

Official title: Electroceutical Dressing Technology Against Wound Microbial Biofilm Infection

Status Completed

Clinical Trial Summary

There are currently limited treatments available that show anti-biofilm efficacy for wound infection management Biofilms account for over 80% of infections and approximately 65% of nosocomial infections caused by microorganisms in the developed world involve biofilms. There clearly is a need for cost effective, highly stable, easily obtained biofilm targeted strategies for treatment of chronic wound biofilm infections.

The information generated from this project has the potential of providing considerable benefits to wound care by determining the efficacy of EDT dressing in managing wound biofilm infection and efficacy in wound healing and closure. Such knowledge could help therapeutic strategies and could provide information for future clinical studies to further understanding -of EDT wound dressings.

Clinical Trial Description

This is a randomized open-label clinical study to test the efficacy of the treatment protocol using an optimized EDThi & EDTlo sequential approach in infected or high risk of infection burn/trauma/surgery chronic wounds against biofilm infection. This trial will determine the efficacy of EDT dressing against wound biofilm infection. subjects will be randomized to one of the two groups: 1) standard of care (SoC) only and 2) SoC + EDT dressing treatment. In group 2, in addition to SoC, the patients will apply the EDThi dressing (PED-10) on the wound(s) for the first 3 weeks following enrollment followed by Procellera® for additional 3 weeks. The use of dressings will be discontinued anytime if complete wound closure is achieved. ;

Related Conditions & MeSH terms

• Wound Heal
• Wounds and Injuries

• NCT number: NCT04794621
• Study type: Interventional
• Source: Indiana University
• Status: Completed
• Phase: N/A
• Start date: June 3, 2021
• Completion date: July 7, 2023